Publisher's Synopsis
This text features a state-of-the-art discussion on the use of SPECT and PET in myocardial imaging and the pitfalls of conventional stress / redistribution thallium studies for detection of severely ischemic or hibernating myocardium. Other contributors highlight the expanding role of SPECT in diagnosing bone disease, explore the use of beta-emitting tracers for palliation of intractable bone pain from metastases and assess the status of radiolabeled monoclonal antibodies. Also included are reviews of nuclear medicine's role in amyloidosis, acquired renal disease and paediatric interventional procedures.
